Press Releases

Jun. 10 Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate BU
May. 18 Sensorion : Inside Information / Other news releases PU
May. 18 Sensorion Appoints Fred Chereau as Chief Executive Officer BU
May. 13 Sensorion : Inside Information / Other news releases PU
May. 13 Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions BU
May. 05 Sensorion Announces its Participation in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting BU
Apr. 22 Sensorion Provides Preliminary Documents for the Combined Shareholders General Meeting of May 11, 2026 AQ
Apr. 21 Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 11, 2026 BU
Mar. 23 Sensorion : Inside Information / Other news releases PU
Mar. 23 Sensorion Reports Six-Month Update from the Audiogene Phase 1/2 Trial of SENS-501 and Advances GJB2-GT (SENS-601) Toward First-in-Human Clinical Development BU
Mar. 18 Sensorion : Inside Information / News release on accounts, results PU
Mar. 18 Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report BU
Feb. 17 Sensorion Announces Leadership Changes BU
Feb. 06 Sensorion : Inside Information / Other news releases PU
Feb. 06 Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting BU
Jan. 29 Sensorion Announces EUR60 Million Financing with a EUR20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists to Advance Genetic Medicine Pipeline AQ
Jan. 28 Sensorion : Inside Information / Other news releases PU
Jan. 28 Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline BU
Dec. 19 Sensorion to Present at the 44th Annual J.P. Morgan Healthcare Conference BU
Dec. 08 Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial BU
25-09-17 Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report BU
25-09-04 Sensorion Announces its Participation in the 60th Annual Inner Ear Biology Workshop BU
25-08-15 Sensorion : Informations privilégiées / Autres communiqués PU
25-08-15 Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux BU
25-07-31 Sensorion Announces Its Participation In Upcoming Investor Conferences BU
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!